Tag Archives: Crestor

Statin Might Reduce Colorectal Cancer

Posted on November 8, 2010 by wngai

Currently, the strategies to look for colon cancer are to detect it early using colonoscopy and fecal occult blood testing.  The ultimate goal to prevent this disease is to use chemoprevention.  Last month, a presentation at the American College of … Continue reading →

Posted in Cancer, Colorectal cancer | Tagged , , , , , , , , | Comments Off on Statin Might Reduce Colorectal Cancer

Beyond Cardiovascular Benefits – NSAID and Statin Reduce the Cancer Risk with PPI-Treated Barrett’s Esophagus

Posted on March 23, 2010 by wngai

It is well known that NSAID (Advil, Motrin and Aspirin) and statin (Zocor, Mevacor, Lipitor, Crestor, Pravachol and Lescol) offer cardiovascular benefits. However, a new study published in the February issue of Gastroenterology suggested that non-steroidal anti-inflammatory drugs (NSAIDs) and … Continue reading →

Posted in Cancer, Esophageal Cancer | Tagged , , , , , , , , , , , , , , | Comments Off on Beyond Cardiovascular Benefits – NSAID and Statin Reduce the Cancer Risk with PPI-Treated Barrett’s Esophagus

Rosuvastatin approved for reducing cerebral/cardiovascular events in LDL normal individuals

Posted on February 17, 2010 by wngai

FDA has approved to expand the label of rousuvastatin (Crestor, Astra Zeneca).  The new label allowed rousuvastatin to be used to reduce the risk of stroke, MI and revascularization procedures in individuals who have normal LDL levels and no coronary … Continue reading →

Posted in Cardiovascular disease, Heart attack, High cholesterol, Stroke | Tagged , , , , , | Comments Off on Rosuvastatin approved for reducing cerebral/cardiovascular events in LDL normal individuals